This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinicaltrialdata published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinicaltrialdata published in the European Journal of Pain. The 1mg dose showed a significant pain decrease compared to the placebo. .”
However, there has not been a clinicaltrial assessing the efficacy of cannabis for migraines, at least not until now. Science Alert has announced that the first clinicaltrial for cannabis as a migraine treatment is underway. The First ClinicalTrial for Migraines and Cannabis.
IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinicaltrial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.
MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. Like THC , CBN is a natural anti-inflammatory. CBN acts like a weaker version of THC at CB1 receptors, causing very few of THC’s impairing effects, and also less side effects.
The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinicaldata published in the Journal of Clinical Medicine. Subjects receiving treatment reported no adverse effects.
InMed and CHDR are currently preparing the ClinicalTrial Application for a second Phase 1 clinicaltrial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers.
(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinicaltrial for IGC-AD1. The investigational new drug, IGC-AD1, is IGC’s proprietary Tetrahydrocannabinol (THC)-based candidate designed to treat certain symptoms of Alzheimer’s disease. The degree of the decrease varied by cohort.
Not only this, but Gaize recently completed the largest clinicaltrial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. Keen to learn more about the trial and Gaize’s innovative product, I asked CEO Ken Fichtler some questions. Here’s what he had to say.
The trial , titled “Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial,” was published in the PLoS One journal and outlines the effects of high-THC cannabis use on ulcerative colitis. THC and Inflammation. View original article.
Clinicaltrials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinicaltrials couldn’t have come at a better time.
Geoffrey Guy, chairman of the pharmaceutical company, told reporters that the purified drug contains no tetrahydrocannabinol (THC), the psychotropic ingredient in marijuana causing the recreational high. Source: FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In ClinicalTrials. In the upcoming U.S.
Dr. Goldstein: It appears that CBG does a lot of things that THC does and a lot of things that CBD does — but maybe even a little bit better. It’s kind of a bridge between THC and CBD. CannMed: It’s interesting that you say CBG is a bridge between THC and CBD. CBG is not intoxicating or impairing.
Mugglehead reports… Previous tests with THC in mice with influenza showed an increase in viral loads. A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Twitter Ads info and privacy.
While animal studies have revealed that cannabinoid receptors likely have a role in modulating auditory signaling, there is no compelling data either from animal or human studies for the use of cannabinoids to alleviate tinnitus.” A review of the current literature.” And its conclusion?
This synthetic derivative of naturally occurring delta-9-Tetrahydrocannabinol (delta-9-THC) was first reported by noted cannabis chemist Professor Roger Adams at the University of Illinois in 1940. It was also later found that HHC can be produced in the lab during the conversion of THC to CBN in what is known as a disproportionation reaction.
MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?
However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. million clinicaltrial investigating the effects of CBD on hallucinations and delusions related to the disease.
InMed and CHDR are currently preparing the ClinicalTrial Application for a second Phase 1 clinicaltrial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. However, a result can be statistically significant but not clinically significant–meaning that even though a study may detect a difference on paper, it may make no tangible difference in real-world application.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. THC is the primary psychoactive compound in cannabis.) Epilepsy Behav.
The study was conducted by more than 10 researchers, with leads Dr. Jodi Gilman and Dr. Kevin Potter taking responsibility for the integrity and accuracy of the data. ClinicalTrial Sample Size. Does the Data Justify the Conclusions? Investigating the Impact of MMJ Cards.
The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.
The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC. CBD for Anxiety. How to Use Cannabis for Anxiety.
The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. produced, THC-free 1 CBD products. Sibyl Swift, VP, Scientific & Regulatory Affairs.
CBGA is naturally produced by the cannabis plant, and is the precursor to all of the phyto-, or plant-related cannabinoids like THC, CBD, CBN and CBG. Often CBGA is presumed to interact with CB1 and CB2 receptors, more similar to THC and or CBG, but emerging science suggests this is likely not the case. What does CBGA do?
We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S.
THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. CBD vs CBDA.
According to a new study in the Journal of Clinic Medicine , the use of Tetrahydrocannabinol (THC) could have adverse drug effects when combined with other medications due to drug-drug interactions. Its psychoactive ingredient, THC, has made cannabis a highly used recreational drug for millennia. Cannabis Sativa, a.k.a
First academic study of national medicinal cannabis data. This is despite a limited number of high-quality clinicaltrials investigating the drug’s efficacy for this condition. Historically, the effects of THC have been described as anxiety- inducing , although this may depend on dose size and other factors.”.
For the study, researchers at Washington State University analyzed data from 1,959 anonymous marijuana consumers who tracked their marijuana use and headache frequency over a 16-month period. The study, titled Short and Long-term effects of cannabis on headaches and migraine , can be found by clicking here.
Over the past two decades, PRECLINICAL data indicate that THC, CBD, as well as some synthetic cannabinoids induce apoptosis of cancer cells and inhibit tumor proliferation, metastasis, and angiogenesis. Note: The results of preclinical trials are NOT equivalent to clinicaltrials. What have the results indicated?
Even though scientific data is still somewhat scarce on this topic, several studies confirm that cannabis directly acts on the cells of the immune system affected by HIV. But I haven’t seen any clinicaltrials looking at the direct effects of THC on the virus. 2016 ( 3 ). 2007 ( 6 ).
In fact, THC and various other compounds in the cannabis plant were discovered in Israel by now 87-year-old chemist Raphael Mechoulam, who continues to work at Hebrew University in Jerusalem. We’re also continuing to do some other clinicaltrials in Israel, specifically with our strains.” In the U.S.,
” The systematic review of the literature “was conducted during 2019, assessing the data from all case studies and clinicaltrials involving medicinal cannabis or plant-derived isolates for all major psychiatric disorders (neurological conditions and pain were omitted).”
Completed manufacturing of ANEB-001 capsules for upcoming Phase 2 clinicaltrial. On track to commence Phase 2 proof-of-concept clinicaltrial with ANEB-001 for the treatment of acute cannabinoid intoxication by year-end. Condensed Balance Sheet Data. . . Anebulo Pharmaceuticals, Inc. September 30, 2021. . .
Food and Drug Administration (FDA) during which the company received valuable guidance regarding the clinical development of ANEB-001 in the U.S. Additionally, we are pleased with the guidance provided by the FDA regarding ANEB-001’s clinical and regulatory path in the U.S.
The FDA approved the THC-based drugs Dronabinol and Nabilone to treat extreme weight loss and nausea due to chemotherapy. Nabiximol is a cannnabis derived drug that exited clinicaltrials in Spain. THC’s suppression of the immune system treats chronic inflammation of people undergoing cancer treatments such as chemo.
Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). While many of their effects and uses overlap, the biggest difference between the two is that THC produces a “high” while CBD does not. Chronic pain.
Researchers noted that, for many factors, the data showed “an initial decrease in values but [then an] eventual increase.” Recent clinicaltrialsdata also find that the administration of specific cannabinoids, such as CBD and THC-V, are positively associated with reductions in blood pressure and blood sugar levels.
” Clinicaltrialdata published in 2017 in in the journal European Neuropsychopharmacology previously reported that the administration of whole-plant cannabis extracts is associated with improvements in cognition and behavior in subjects with ADHD. 9-tetrahydrocannabinol (THC).
It has been just over a month since the public comment period closed in the wake of the public hearing held by the FDA, “Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds”. THC by dry weight following the enactment of the 2018 Farm Bill. and its derivatives containing no more than 0.3%
As a Contract Research Organization specialized in medical cannabis, Santé Cannabis offers consultation, data management and clinicaltrial services to a diverse range of clients from pharmaceutical, biotech and cannabis industries. ABOUT SPECTRUM THERAPEUTICS.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content